Oferta pracy

Pracodawca zakończył zbieranie zgłoszeń na tę ofertę

Aktualne oferty pracodawcy

Pracodawca zakończył zbieranie zgłoszeń na tę ofertę

Aktualne oferty pracodawcy

Senior Scientist (Cell and Molecular Biology)

Selvita

Selvita

Michała Bobrzyńskiego 14

Kraków

Your responsibilities

  • Utilizing expertise in various types of projects mainly related to biochemical and cell-based assay development and routine testing of small molecule and protein drug candidates

  • Proactively seeking out new information in the literature and incorporate this into individual projects as well as the overall program

  • Presenting research results and methodologies at weekly meetings with immediate supervisor and project leader, project team meetings and other research forums

  • Mentoring and supervising of junior team members by providing scientific expertise and sharing the technical skills

Our requirements

  • PhD with preferably 2+ years of experience

  • Prior industrial or relevant academic experience

  • Previous experience in the fields of molecular biology and/or cancer biology

  • Expertise in assay development in the area of Drug Discovery (biochemical, enzymatic, coupled, cell-based assays)• Expertise in assay optimization and validation in GMP (e.g. for batch release testing)

  • Technical expertise with mammalian cell culture (essential), standard molecular biology techniques like ELISA, Western Blot, qPCR, as well as cytotoxicity, proliferation, apoptotic and cellular reporter system assays

  • Expertise with flow cytometry, cytokine release, cytotoxicity and proliferation assays is strongly preferred

  • Experience in working with cell lines and cell-based assays in microplate format (experience with 3D assays will be a plus)

  • Expertise in working in GxP environment is preferred

  • Practical experience with analysis software such as FlowJo, GraphPad Prism, Excel is strongly preferred

  • Ability to manage large amounts of data and to supervise less experienced scientists/research assistants

  • Willingness to learn and adopt new experimental techniques

  • Good knowledge of written and spoken English

What we offer

  • Highly important work in a dynamic environment of a continuously developing stock-listed company

  • Work in a multicultural environment and an insight into fascinating biotech industry

  • An opportunity for a versatile career path development

  • Long-term cooperation based on stable employment conditions

  • Competitive basic salary & bonus opportunities

  • Benefits

  • private medical care

  • sharing the costs of foreign language classes

  • life insurance

  • fruits

  • integration events

  • corporate gym

  • corporate sports team

  • no dress code

  • coffee / tea

  • kindergarten / nursery

  • christmas gifts

  • employee referral program

  • charity initiatives

  • family picnics

  • Multisport card

Selvita

Selvita is a global integrated drug discovery partner for the pharmaceutical and biotechnology industries with offices in Cambridge, UK, Greater Boston Area, and San Francisco Bay Area. Headquartered in Poland, with laboratories located in Krakow and Poznan, the company offers drug discovery support at every stage of the early discovery phase up to the preclinical research phase.

Scroll to the company’s profile

As a Senior Scientist in the field of cell and molecular biology, You’ll play a vital role in the Drug Discovery processes based on Structure-Activity Relationship studies or testing of drug substances and products in the GMP environment for biotech and pharma companies from Europe, USA and the rest of the world. You’ll be working in a friendly and collaborative environment created by open-minded people, always ready for new challenges that new projects can bring, with an everyday opportunity to exchange knowledge with experienced members of the team. The variety of projects we run offers an opportunity to profile career path in an interesting and diverse way.

Please have in mind, that some benefits might be currently on hold due to pandemics.